Allogeneic human mesenchymal stem cells

Mesenchymal stem cells · Longeveron Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allogeneic human mesenchymal stem cells, covering 2021-04-27 to 2022-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease [Phase 2]